🇺🇸 FDA
Patent

US 6271196

Methods of alleviating neuropathic pain using prosaposin-derived peptides

expired A61KA61K38/00A61P

Quick answer

US patent 6271196 (Methods of alleviating neuropathic pain using prosaposin-derived peptides) held by Regents of the University of CA expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Regents of the University of CA
Grant date
Tue Aug 07 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61P, A61P25/00, A61P25/02